1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimers disease;1-h mrs promjene u dorzolateralnom prefrontalnom korteksu nakon primjene donepezila u pacijenata s blagim i umjerenim oblicima Alzhemierove bolesti

Collegium Antropologicum

Volumn 35, Issue SUPPL. 1, 2011, Pages 159-162

  Henigsberg, Neven ^a,b   Kalember, Petra ^b,c   Hrabač, Pero ^b   Radoš, Marko ^b,d   Bajs, Maja ^d   Radoš, Milan ^b,d   Kovačić, Zrinka ^b   Lončar, Mladen ^d   Madžar, Tomo ^b  

^a Referentni centar za Alzheimerovu bolest i psihijatriju sta rijeivo t ne dobi   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Neuron Polyclinic   (Croatia)

^d KBC Zagreb   (Croatia)

Author keywords

1H MRS; Alzheimer's disease; Donepezil

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; CHEMISTRY; COGNITION; COHORT ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PREFRONTAL CORTEX;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; COHORT STUDIES; FEMALE; HUMANS; INDANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; PREFRONTAL CORTEX;

EID: 79952021640     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LOCKHART IA, MITCHELL SA, KELLY S, Dement Geriatr Cogn Disord, 28 (2009) 389.
2. RAINA P, SANTAGUIDA P, ISMAILA A, PATTERSON C, COWAN D, LEVINE M, BOOKER L, OREMUS M, Ann Intern Med, 148 (2008) 379.
3. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR, J Psychiatr Res, 12 (1975) 189.
4. ROSEN WG, MOHS RC, DAVIS KL, Am J Psychiatry, 141 (1984) 1356.
5. WESNES KA, Neurodegener Dis, 5 (2008) 261.
6. BIRKEN DL, OLDENDORF WH, Neurosci Bio-behav Rev, 13 (1989) 23.
7. SIMMONS ML, FRONDOZA CG, COYLE JT, Neuroscience, 45 (1991) 37.
8. SEPPI K, Parkinsonism Relat Disord, 13S (2007) 400.
9. TRABESINGER AH, MEIER D, BOESIGER P, Magn Reson Imaging, 21 (2003) 1295.
10. FIRBANK MJ, HARRISON RM, O'BRIEN JT, Dement Geriatr Cogn Disord, 14 (2002) 64.
11. SCHOCKE MF, BERGER T, FELBER SR, WOLF C, DEISENHAMMER F, KREMSER C, Neuroimage, 20 (2003) 1253.
12. TSAI G, COYLE JT, Prog Neurobiol, 46 (1995) 531.
13. KRISHNAN KR, CHARLES HC, DORAISWAMY PM, WEISLER R, YU X, PERDOMO C, IENI JR, Am J Psychiatry, 160 (2003) 2003.
14. BARTHA R, SMITH M, RUPSING H, RYLETT J, WELLS JL, BORRIE MJ, Prog NeuroPsychopharmacol Biol Psych, 32 (2008) 786.
15. COH-ENGADOL AA, PAN JW, KIM JH, SPENCER DD, HETHERINGTON HH, J Neurosurg, 101 (2004) 613.
16. WILKINSON D, SCHINDLER R, SCHWAM E, WALDEMAR G, JONES RW, GAUTHIER S, LOPEZ OL, CUMMINGS J, XU Y, FELDMAN HH, Dement Geriatr Cogn Disord, 28 (2009) 244.
17. ROSE SE, DE ZU-BICARAY G.I., WANG D, GALLOWAY GJ, CHALK JB, EAGLE SC, Magn Reson Imaging, 17 (1999)291.
18. PFEFFERBAUM A, ADALSTEIN-SSON E, SPIELMAN D, SULLIVAN EV, LIM KO, Magn Reson Med, 41 (1999) 276.
19. PARNETTI L, TARDUCCI R, PRESCIUTTI O, LO-WENTHAL DT, PIPPI M, PALUMBO B, Mech Ageing Dev, 97 (1997) 9.
20. KRISHNAN KR, CHARLES HC, DORAISWAMY PM, MINTZER J, WEISLER R, YU X, PERDOMO C, IENI JR, ROGERS S, Am J Psychiatry, 160 (2003) 2003.
21. MODREGO PJ, PINA MA, FAYED N, DIAZ M, CNS Drugs, 20 (2006) 867.